These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21847118)

  • 1. Second cancer incidence and cancer mortality among chronic lymphocytic leukaemia patients: a population-based study.
    Royle JA; Baade PD; Joske D; Girschik J; Fritschi L
    Br J Cancer; 2011 Sep; 105(7):1076-81. PubMed ID: 21847118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Veterans with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) have a markedly increased rate of second malignancy, which is the most common cause of death.
    Kyasa MJ; Hazlett L; Parrish RS; Schichman SA; Zent CS
    Leuk Lymphoma; 2004 Mar; 45(3):507-13. PubMed ID: 15160912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Australians with chronic lymphocytic leukaemia continue to have high rates of second primary malignancies in the modern era.
    Baggio D; Chung E; Wellard C; Waters N; Cushion T; Chong G; Cochrane T; Cull G; Giri P; Hamad N; Johnston A; Lee D; Murali A; Morgan S; Mulligan S; Talaulikar D; Ratnasingam S; Wood E; Hawkes E; Opat S
    Intern Med J; 2024 Jul; 54(7):1223-1227. PubMed ID: 38973146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemia.
    Falchi L; Vitale C; Keating MJ; Lerner S; Wang X; Elhor Gbito KY; Strom S; Wierda WG; Ferrajoli A
    Ann Oncol; 2016 Jun; 27(6):1100-1106. PubMed ID: 26912560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of second cancer after chronic lymphocytic leukemia.
    Schöllkopf C; Rosendahl D; Rostgaard K; Pipper C; Hjalgrim H
    Int J Cancer; 2007 Jul; 121(1):151-6. PubMed ID: 17351903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype.
    Morton LM; Curtis RE; Linet MS; Bluhm EC; Tucker MA; Caporaso N; Ries LA; Fraumeni JF
    J Clin Oncol; 2010 Nov; 28(33):4935-44. PubMed ID: 20940199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of primary haematologic cancers following incident non-metastatic breast cancer: A Danish population-based cohort study.
    Hjorth CF; Farkas DK; Schapira L; Cullen MR; Sørensen HT; Cronin-Fenton D
    Cancer Epidemiol; 2023 Feb; 82():102311. PubMed ID: 36508968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
    Hisada M; Chen BE; Jaffe ES; Travis LB
    J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased serum C-reactive protein levels are associated with shorter survival and development of second cancers in chronic lymphocytic leukemia.
    Herishanu Y; Polliack A; Shenhar-Tsarfaty S; Weinberger R; Gelman R; Ziv-Baran T; Zeltser D; Shapira I; Berliner S; Rogowski O
    Ann Med; 2017 Feb; 49(1):75-82. PubMed ID: 27595291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival.
    Herr MM; Schonfeld SJ; Dores GM; Withrow DR; Tucker MA; Curtis RE; Morton LM
    J Natl Cancer Inst; 2018 Nov; 110(11):1248-1258. PubMed ID: 29659938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late mortality and second cancers in an Australian cohort of childhood cancer survivors.
    Wilson CL; Cohn RJ; Johnston KA; Ashton LJ
    Med J Aust; 2010 Sep; 193(5):258-61. PubMed ID: 20819041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second primary cancers in patients with acute lymphoblastic, chronic lymphocytic and hairy cell leukaemia.
    Zheng G; Chattopadhyay S; Sud A; Sundquist K; Sundquist J; Försti A; Houlston R; Hemminki A; Hemminki K
    Br J Haematol; 2019 Apr; 185(2):232-239. PubMed ID: 30706458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Merkel cell carcinoma: incidence, mortality, and risk of other cancers.
    Kaae J; Hansen AV; Biggar RJ; Boyd HA; Moore PS; Wohlfahrt J; Melbye M
    J Natl Cancer Inst; 2010 Jun; 102(11):793-801. PubMed ID: 20424236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of second primary cancer and death following a diagnosis of nonmelanoma skin cancer.
    Nugent Z; Demers AA; Wiseman MC; Mihalcioiu C; Kliewer EV
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2584-90. PubMed ID: 16284382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of an association between non-Hodgkin's lymphoma and skin cancer.
    Adami J; Frisch M; Yuen J; Glimelius B; Melbye M
    BMJ; 1995 Jun; 310(6993):1491-5. PubMed ID: 7787593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second cancers in patients with chronic lymphocytic leukemia.
    Travis LB; Curtis RE; Hankey BF; Fraumeni JF
    J Natl Cancer Inst; 1992 Sep; 84(18):1422-7. PubMed ID: 1512794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolism in chronic lymphocytic leukemia: a Danish nationwide cohort study.
    Gade IL; Riddersholm SJ; Christiansen I; Rewes A; Frederiksen M; Enggaard L; Poulsen CB; Bergmann OJ; Gillström DB; Pedersen RS; Nielsen L; Eriksen HH; Torp-Pedersen C; Kristensen SR; Severinsen MT
    Blood Adv; 2018 Nov; 2(21):3025-3034. PubMed ID: 30425066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland.
    McKenna DB; Stockton D; Brewster DH; Doherty VR
    Br J Cancer; 2003 Jan; 88(1):74-8. PubMed ID: 12556962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.
    Brewer JD; Shanafelt TD; Call TG; Cerhan JR; Roenigk RK; Weaver AL; Otley CC
    Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.